Status:
COMPLETED
Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Endometriosis
Eligibility:
FEMALE
18-45 years
Phase:
PHASE2
Brief Summary
The purpose of this investigational study is to determine if a study medication is safe and effective in reducing the symptoms associated with endometriosis; if the study medication reduces the need f...
Eligibility Criteria
Inclusion
- Surgical diagnosis of endometriosis within 5 years
- Not pregnant and not lactating
- Willing to use non-hormonal contraception, history of regular menstrual cycles
Exclusion
- Hysterectomy, surgical treatment for endometriosis within 3 months
- Certain medications for the treatment of endometriosis
- Previous history of a malignancy
- Abnormalities on physical or gyn exams and abnormal lab tests
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
End Date :
December 1 2006
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00110487
Start Date
January 1 2005
End Date
December 1 2006
Last Update
May 1 2015
Active Locations (46)
Enter a location and click search to find clinical trials sorted by distance.
1
Phoenix, Arizona, United States, 85015
2
Tucson, Arizona, United States, 85710
3
Carmichael, California, United States, 95608
4
La Jolla, California, United States, 92093